Back to Polar Capital Holdings Plc

XENE
Showing 8 of 18 quarters

Position history for Polar Capital Holdings Plc's holdings in XENON PHARMACEUTICALS INC

Polar Capital Holdings Plc holds 4.4M shares of XENE (XENON PHARMACEUTICALS INC), worth $256.2M as of 2026-Q1. The position was increased (+78.7% shares). XENE represents 0.9% of Polar Capital Holdings Plc's portfolio.

Current Value

$256.2M

Current Shares

4.4M

Total Value Change

+$157.3M

Total Shares Change

+1.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
4.4M
+78.7%
$256.2M0.9%$43.79
66
2025-Q4
Decreased
2.5M
-3.2%
$110.5M0.4%$44.12
0
2025-Q3
Decreased
2.5M
-5.8%
$102.3M0.5%$39.06
0
2025-Q2
Increased
2.7M
+3.1%
$84.6M0.4%$32.40
37
2025-Q1
Decreased
2.6M
-2.8%
$88M0.5%$34.26
0
2024-Q4
Increased
2.7M
+10.3%
$105.7M0.6%$38.53
47
2024-Q3
Decreased
2.4M
-3.6%
$96.2M0.5%$38.65
0
2024-Q2
Decreased
2.5M
-2.9%
$98.9M0.6%$38.99
0

Other major holders of XENE: FMR LLC, Avoro Capital Advisors LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used